.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Notably, the Mumbai-based nutrition startup TruNativ recently secured approximately $30 million (about Rs 283.5 crore) in its Series B funding round. Crucially, the global healthcare investment firm OrbiMed led this capital infusion. Consequently, this major investment highlights why preventive nutrition is now a critical clinical priority in India.
Historically, Indian consumers have remained severely underserved by typical dietary options. Specifically, many modern products promise health benefits but deliver unhealthy compromises, leading to widespread protein deficiencies. Furthermore, local populations face massive overexposure to refined sugars. Therefore, TruNativ developed clean-label products to address these daily clinical gaps in Indian households. Subsequently, OrbiMed senior executives Sunny Sharma and Sumona Chakraborty will join TruNativ’s board. As a result, the startup will combine strong corporate governance with a clear medical focus.
Indeed, the Mumbai-based company will utilize the newly raised capital to expand its nationwide distribution network. Specifically, this expansion will cover direct-to-consumer platforms, quick commerce, modern trade, and pharmacies. Additionally, TruNativ will deploy significant resources to scale its B2B2C ingredient business. Currently, this segment supplies science-backed nutrition solutions to several major consumer brands in India. Thus, doctors can expect a higher availability of healthier alternatives across various therapeutic categories. In addition, the brand plans to establish a new research and development center to drive medical food innovation.
Essentially, TruNativ operates across high-growth nutrition sectors including sugar substitutes, proteins, gut health, and beauty wellness. Since then, the company has focused on providing clean-label products. For instance, these products help patients manage diabetes risks and improve gastrointestinal function. Consequently, doctors can recommend these science-backed dietary choices to support ongoing therapeutic interventions. Ultimately, this significant capital injection will accelerate the accessibility of preventive healthcare options throughout India.
Q1: Who led the Series B funding round for TruNativ?
OrbiMed, a leading global healthcare investment firm, led the $30 million Series B funding round for TruNativ.
Q2: What are the main product categories offered by TruNativ?
TruNativ operates across key preventive nutrition areas, including sugar alternatives, protein supplements, gut health, and beauty wellness products.
Q3: How will TruNativ utilize the newly raised Series B funds?
The company will use the funds to expand its retail and pharmacy distribution network, grow its B2B2C ingredient division, and build a new R&D center.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Mumbai-based startup TruNativ has raised $30 million in a Series B round led by OrbiMed. This investment highlights the growing importance of clean-label, nutrition-focused products to tackle India's widespread protein deficiency and sugar overexposure.
2 months ago
A nationwide mixed-methods study evaluated hospital glycemic management systems across 265 hospitals. While real-time alerts and automatic data sync are highly valued, significant disparities in digital maturity and low satisfaction with decision support highlight the need for standardized implementation.
Last week
Private equity firm LeapFrog Investments plans to deploy up to $100 million across Indian healthcare over the next two years. The capital will target asset-light delivery models, non-metro hospital networks, diagnostics, and single-specialty clinical infrastructure.
Last week
The Food Safety and Standards Authority of India has proposed front-of-pack warning labels with a red hexagonal graphic for packaged items high in sugar, fat, or salt. This critical public health initiative aims to combat non-communicable diseases and empower consumers across the country.
Last week
Nearly 80% of Indians suffer from inadequate Vitamin D, causing silent bone weakening and sudden fractures. This expert guide reviews why mega-dose therapy is critical for high-risk patients, the key factors driving widespread deficiency, and the mandatory medical evaluations needed to protect skeletal health.
2 months ago
The Supreme Court of India has sharply criticized the Food Safety and Standards Authority of India for delaying front-of-package warning labels. With non-communicable diseases causing over 6 million deaths annually, clear nutritional warnings are critical to combat childhood obesity, diabetes, and cardiovascular risk.
3 weeks back
